Changes

166 bytes removed ,  22:20, 24 June 2018
Line 38: Line 38:     
By far the most common ''BCR'' alteration associated with cancer is the BCR-ABL1 fusion as described above in CML and ALL.  
 
By far the most common ''BCR'' alteration associated with cancer is the BCR-ABL1 fusion as described above in CML and ALL.  
  −
A number of other gene fusion partners have been identified with ''ABL1'' and linked to other hematological cancers, but at a much smaller prevalence than BCR-ABL1.
      
A small number of individual patients have been described with a BCR-JAK2 (Janus Kinase 2) fusion gene leading to CML and other hematological neoplasms, but this fusion gene appears to be rare (see '''[http://atlasgeneticsoncology.org/Anomalies/t0922p24q11ID1331.html] Atlas of Genetics and Cytogenetics in Oncology and Haematology]''') [12,13,14].
 
A small number of individual patients have been described with a BCR-JAK2 (Janus Kinase 2) fusion gene leading to CML and other hematological neoplasms, but this fusion gene appears to be rare (see '''[http://atlasgeneticsoncology.org/Anomalies/t0922p24q11ID1331.html] Atlas of Genetics and Cytogenetics in Oncology and Haematology]''') [12,13,14].